Patients with rs2289590 (AURKB) heterozygous AC genotype had a lower risk of glioblastoma multiforme (GBM) development in comparison with the reference AA genotype (OR = 0.54, 95% CI = 0.33–0.88, P = 0.015) (Table 4). Here, AURKB is linked to glioblastoma.